Fingerprint
Dive into the research topics where Seung Joon Oh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial
Hong, E. G., Min, K. W., Chun, S. W., Chung, C. H., Oh, S., Lee, C. B., Kim, D. J., Kim, H. S., Mok, J. O., Sohn, T. S., Park, J. H., Choi, S. H., Kim, S., Kim, S. S., Hur, K. Y., Kim, C. H., Cho, Y. M., Kim, B. J. & Yoon, K. H., Oct 2025, In: Diabetes, Obesity and Metabolism. 27, 10, p. 5727-5736 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study)
Hong, S., Kim, W. J., Kang, E. S., Jeong, I. K., Kim, C. H., Lee, K. Y., Kim, S., Oh, S. J. & Lee, C. B., Mar 2025, In: Diabetes, Obesity and Metabolism. 27, 3, p. 1242-1250 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
Lim, S., Lee, S. H., Min, K. W., Lee, C. B., Kim, S. Y., Yoo, H. J., Kim, N. H., Kim, J. H., Oh, S., Won, J. C., Kwon, H. S., Kim, M. K., Park, J. H., Jeong, I. K. & Kim, S., 1 Jun 2024, In: Diabetes, Obesity and Metabolism. 26, 6, p. 2188-2198 11 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus) -
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trial
Kwak, S. H., Han, K. A., Kim, E. S., Choi, S. H., Won, J. C., Yu, J. M., Oh, S., Yoo, H. J., Kim, C. H., Kim, K. S., Chun, S. W., Kim, Y. H., Cho, S. A., Kim, D. H. & Park, K. S., Oct 2024, In: Diabetes, Obesity and Metabolism. 26, 10, p. 4203-4212 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial
Kwak, S. H., Han, K. A., Kim, K. S., Yu, J. M., Kim, E. S., Won, J. C., Kang, J. G., Chung, C. H., Oh, S., Choi, S. H., Won, K. C., Kim, S. G., Cho, S. A., Cho, B. Y. & Park, K. S., Jul 2023, In: Diabetes, Obesity and Metabolism. 25, 7, p. 1865-1873 9 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Citations (Scopus)
Press/Media
-
Kyung Hee University Reports Findings in Pseudomonas putida (Efficient biological funneling of lignin into 2-pyrone-4,6-dicarboxylic acid via electrocatalytic depolymerization and genetically engineered Pseudomonas putida KT2440)
Oh, S. J., Joo, J. C., Kim, H. C., Park, J.-W., Kim, H., Kim, S. H., Oh, S. J., Park, J. H., Kim, H. & Song, M. K.
18/03/25
1 item of Media coverage
Press/Media